Sign up to receive our twice-weekly e-Newsletter
HIV
and
Hepatitis
.com
Internet Symposium
*This coverage is not sanctioned by the conference organizers and is not an official part of the conference proceedings.
Library of CME/CE Programs
CME/CE Talking Slides* Update
Assessing Best
Practices in HIV/AIDS
Therapy - Independent
Coverage of ICAAC 2009
CME-Certified Webcast
CME/CE-Certified Activity
CME Audio Webcast
HIV CME WEBCAST:
Maintaining Cardiovascular Health in HIV-positive Patients
HIV
Program Details
CME Audio Webcast
THE RESISTANCE REVOLUTION:
Prevention and Management
of Resistance in Patients
With Chronic Hepatitis B
HEPATITIS
Program Details
CME/CE Talking Slides Update
EASL 2009 CME/CE
Independent Coverage
of EASL 2009:
Talking Slides Update
HEPATITIS
Program Details
CME NEWSLETTER
EASL 2009 CME/CE
Assessing Best Practices
in HBV Therapy
2009 CME/CE
Newsletter Update
HEPATITIS
Program Details
HIV and Hepatitis.com Coverage of the
60
th
Annual Meeting of the American Association
for the Study of Liver Diseases (
AASLD 2009
)
October 30 - November 3, 2009, Boston, MA
Library of Posters and Slides
HEPATITIS B and C
-
Top News Articles
November 6, 2009
SPRINT-1 Study Shows Benefits of Response-guided Therapy with Experimental HCV Protease Inhibitor Boceprevir
Experimental HCV Protease Inhibitor BI 201335 Demonstrates Promising Results in Combination with Pegylated Interferon and Ribavirin
Tenofovir (Viread) Regimens Are Effective and Well-tolerated in Chronic Hepatitis B Patients with Decompensated Liver Disease
November 3, 2009
Long-term Studies Show Tenofovir (Viread) Safety and Efficacy Is Sustained at 3 Years in HBeAg Positive and Negative Hepatitis B Patients
Entecavir (Baraclude) Demonstrates Greater Antiviral Activity than Adefovir (Hepsera) in Hepatitis B Patients with Decompensated Liver Disease
Pegylated Interferon Lambda Demonstrates Good Antiviral Activity, May Cause Fewer Side Effects than Interferon Alfa
Liver Transplant Outcomes Have Improved over Time for Patients with and without Hepatitis C
More
Hepatitis B
and
Hepatitis C
Articles
HIV AND AIDS
-
Top News Articles
November 6, 2009
How Much Ritonavir (Norvir) Is Needed to Boost HIV Protease Inhibitors?
Mathematical Model Shows Opt-out HIV Testing Would Save Lives
Bold Efforts to Find a Cure for HIV AIDS and New Prevention Tools Are Urgently Needed, NIAID Director Says
Conant Foundation to Hold HIV and Influenza Forum in San Francisco on November 10
November 3, 2009
Raltegravir (Isentress) Has Durable Antiviral Activity and Remains Well-tolerated after 3 Years
Longer STEP Follow-up Suggests Adenovirus HIV Vaccine Did Not Increase Infection Risk, May Lower Viral Set-point
President Obama Signs Ryan White Act, HIV Travel and Immigration Ban Will Be Lifted Early Next Year
More HIV and AIDS Articles
COINFECTION
-
Top News Articles
November 6, 2009
New HCV Infection Is Occurring among HIV Positive U.S. Men, ACTG Analysis Shows
Tenofovir (Viread) Suppresses HBV Viral Load Long-term in HIV/HBV Coinfected Patients, but Kidney Function May Decline
HIV-HCV Coinfected Patients Are More Likely to Experience HCV Relapse after Completing Treatment, Usually within 12 Weeks
Cochrane Review of Pegylated Interferon Plus Ribavirin for Hepatitis C Treatment in People with HIV
More
HIV-HCV Coinfection
and
HIV-HBV Coinfection
Articles
MOST RECENT CONFERENCE COVERAGE
60th
Annual Meeting of the American Association
for the Study of Liver Diseases (AASLD 2009)
October 30 - November 3, 2009, Boston, MA
49th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2009)
July 19 - 22, 2009, Cape Town, South Africa
5th IAS Conference on HIV Pathogenesis, Treatment and
Prevention (IAS 2009)
July 19 - 22, 2009, Cape Town, South Africa
Digestive Disease Week (DDW 2009)
May 30 - June 4, 2009, Chicago, Illinois
44th Annual Meeting of the European Association for
the Study of the Liver (EASL 2009)
April 22 - 26, 2009, Copenhagen, Denmark
13th International Symposium on Viral Hepatitis and
Liver Disease (ISVHLD 2009)
March 20 - 24, 2009, Washington, DC
16th Conference on Retroviruses
and Opportunistic Infections
(CROI 2009)
February 8 - 11, 2009, Montreal, Canada
Ninth International Congress on Drug Therapy in HIV Infection (HIV9)
November 9 - 13, 2008, Glasgow, UK